TransMed7, LLC Announces Strategic Engagement with Wilson Sonsini Goodrich and Rosati
TransMed7, LLC, announced a Strategic Engagement with the firm of Wilson Sonsini Goodrich and Rosati (WSGR) effective May 22, 2018. Wilson Sonsini is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. The firm represents companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations. Their services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, and technology licensing and other intellectual property transactions, among other areas.
Wilson Sonsini are consistently named one of “America’s Best Corporate Law Firms” by Corporate Board Member. Over the last five years, Wilson Sonsini has completed more than 100 public equity and debt offerings helping clients raise more than $50 billion and has provided representation in more than 500 merger & acquisition transactions valued at over $150 billion.
According to Dr. James W. Vetter, TransMed7 Co-Founder, and Chairman, “Wilson Sonsini’s established leadership position is based on their ability to provide legal services characterized by innovative advice and dynamic perspectives. I believe that they are a perfect match for TransMed7. We fully intend to benefit from the synergy of our unique business strategy with their deep breadth of expertise, including strategic and legal advice relating to technology development, equity transactions, mergers and acquisitions, technology licensure, and strategic planning and execution as we continue to introduce new breakthrough technologies across the board in medical interventional systems.”
